Loading

Loading page data

Please wait a moment

UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -
Request For Customization Radioligand Therapy Market by Isotope (Lutetium-177 (Lu-177), Actinium-225 (Ac-225), Iodine-131 (I-131), Radium-223, Gallium-68, Fluorine-18, Others), Target (Prostate-Specific Membrane Antigen (PSMA), Somatostatin Receptor (SSTR), Epidermal Growth Factor Receptor (EGFR), Gastrin-Releasing Peptide Receptor (GRPR), Others), Indication (Prostate Cancer, Neuroendocrine Tumors (NETs), Breast Cancer, Lung Cancer, Pancreatic Cancer, Others), End-user, and Regional Analysis from 2026 - 2033